Patients with a mutation in RASA1 are at a higher risk of developing Parkes–Weber syndrome, which presents itself as a disease with upper and lower extremity lymphedema with some cases of chylothorax and/or chylous ascites [33]. This evidence concerns the gene RASA1 and Chylothorax.